U.S. flag

An official website of the United States government

Filters

reset all
See more specimen types...

Other countries

Results: 21 to 40 of 93

Tests names and labsConditionsGenes, analytes, and microbesMethods

Top 99 Genetic Causes of Developmental Delay Panel

PreventionGenetics, part of Exact Sciences
United States
17099
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Variant Resolution Test for CancerNext® (+RNAinsight®)

Ambry Genetics
United States
3639
  • D Deletion/duplication analysis
  • R RNA analysis
  • C Sequence analysis of the entire coding region

Invitae Genetic Health Screen

Labcorp Genetics (formerly Invitae) LabCorp
United States
409164
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Cancer Screen

Labcorp Genetics (formerly Invitae) LabCorp
United States
16062
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Variant Resolution Test for CustomNext-Cancer® (+RNAinsight®)

Ambry Genetics
United States
9090
  • D Deletion/duplication analysis
  • R RNA analysis
  • C Sequence analysis of the entire coding region

Variant Resolution Test for CancerNext-Expanded® (+RNAinsight®)

Ambry Genetics
United States
8890
  • D Deletion/duplication analysis
  • R RNA analysis
  • C Sequence analysis of the entire coding region

CDH1 gene sequence and deletion/duplication

Ambry Genetics
United States
61
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CustomNext-Cancer®

Ambry Genetics
United States
9490
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CancerNext®

Ambry Genetics
United States
3739
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CancerNext-Expanded®

Ambry Genetics
United States
8689
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

BRCAPlus®

Ambry Genetics
United States
1113
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Hereditary Breast and Ovarian Cancer - Expanded and Lynch Syndrome Panel

PreventionGenetics, part of Exact Sciences
United States
2933
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Hereditary Breast and Ovarian Cancer - High Risk and Lynch Syndrome Panel

PreventionGenetics, part of Exact Sciences
United States
1917
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Hereditary Ovarian Cancer Panel

PreventionGenetics, part of Exact Sciences
United States
4030
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Invitae Hereditary Hyperekplexia Panel

Labcorp Genetics (formerly Invitae) LabCorp
United States
2313
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Epilepsy Panel

Labcorp Genetics (formerly Invitae) LabCorp
United States
466297
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Dystonia Comprehensive Panel

Labcorp Genetics (formerly Invitae) LabCorp
United States
6138
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Comprehensive Panel for Individualized Cancer Threatment

GeneKor MSA
Greece
1652
  • D Deletion/duplication analysis
  • X Mutation scanning of select exons
  • E Sequence analysis of select exons
  • T Targeted variant analysis

CDH1 MLPA

Institute for Human Genetics University Medical Center Freiburg
Germany
61
  • D Deletion/duplication analysis

OncoGeneDx Custom Panel

GeneDx
United States
10382
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Results: 21 to 40 of 93

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.